Mammalian Manufacturing of Biologics
GTP Bioways offers expert end-to-end services for the mammalian manufacturing of standard mAbs as well as challenging antibody formats and proteins.
Expert CDMO for mammalian manufacturing of proteins & mAbs
GTP Bioways provides solutions for every step of your biotherapeutic development in a mammalian expression system, including process and analytical development, preclinical and clinical supply.
Our best-in-class cGMP facilities are equipped with single-use technologies to allow for flexible production of drug substances and drug products with rapid turnaround times.
Our seasoned team has more than 15 years of experience in mammalian process development & manufacturing. Whether your therapeutic candidate is a standard mAb or a challenging recombinant protein, we will offer a tailored approach, finely tuned to overcome your specific challenges.
We turn your idea into a product through our end-to-end services
A complete development and manufacturing solution for your biopharmaceuticals
GTP Bioways’ activities cover the full development cycle of your biotherapeutics, from cell line development to complete process & analytical development and cGMP manufacturing.
-
- For standard mAbs, we apply our optimised platform manufacturing process to shorten the time to clinic.
- For other proteins, we draw on our unique agility in developing customised solutions to deliver the most efficient, robust and cost-effective process.
Our development and manufacturing activities are supported from early development stages by our QC and QA team, to ensure the highest quality of service and compliance with regulatory requirements.
We offer customized solutions, contact us to discuss your project
GTP Bioways started providing custom recombinant protein production services in 2000 to accelerate biopharmaceutical development and overcome a wide range of challenges.
